test

current companies

Filter:
  • Filter:
  • All
  • #
  • a
  • b
  • c
  • d
  • e
  • f
  • g
  • h
  • i
  • j
  • k
  • l
  • m
  • n
  • o
  • p
  • q
  • r
  • s
  • t
  • u
  • v
  • w
  • x
  • y
  • z
  • 37C - Artful solutions to scientific challenges 37C provides bespoke biotechnology services and scientific support to clients in the pharma and biotech industry. Their mission is to help industrial research teams break the stalemate between the need for continuous innovation and the mandate to deliver results on time and within budget.

  • Screening the world's population for Myotonic Dystrophy and other trinucleotide repeat disorders. 3X Genetics seeks to improve lives by accelerating the diagnosis of GRE diseases, which are common and often misdiagnosed. There are 69 known GREs, including Myotonic Dystrophy, Fuchs Endothelial Corneal Dystrophy (FECD), Friedreich’s Ataxia (FA), Huntington’s Disease, Fragile X, and Spinocerebellar Ataxias (SCAs).

  • AAVinue, Inc.

    AAVinue, Inc. is a pre-seed stage biotech startup, pioneering development of advanced AAVs (adeno-associated viruses) capable of evading neutralizing antibodies and providing deep tissue penetration to allow increased patient access to life-saving therapies.

  • Advirna

    Innovative solutions for oligonucleotide delivery. ADViRNA's goal is to make gene knockdowns simple, efficient and fast.

  • Boston Harbor Biotechnologies

    Boston Harbor Biotechnologies was established by a team of experts to meet the growing demand for comprehensive services within the cell and gene therapy (CGT) community. Our mission is to support a broad spectrum of research and development needs, from discovery through process and assay development to IND-enabling studies and CMC tech transfer readiness.

  • CG Scientific

    CG Scientific Inc. is an early-stage startup focused on commercializing a novel strategy for treating type 1 diabetes.

  • Codomax

    Codomax applies its Epi-MAX platform technology to re-engineer strains and expression vectors to enable maximal production of difficult-to-express biologics.

  • Conifer Life Sciences Group

    Conifer Life Sciences is a firm fostering development of new ventures in the life science tools industry.

  • Conigen Bioscience

    Conigen Bioscience Inc. is a life science tools company that integrates state-of-art immunology, virology, molecular biology and cell biology to create new reagents and high-quality assays for discovery, development, and manufacturing.

  • Eascra Biotech

    Based on DNA nanotechnology, Eascra's novel family of Janus base nanomaterials provides highly effective, super biocompatible solutions that enable enhanced therapeutic delivery and regenerative medicine for articular cartilage, central nervous system disorders, solid tumors, and other chronic conditions.

  • Easy Text AI

    Making web text so simple we understand it the first time we read it. Easy Text AI teaches AI to make text easy to understand and do all we can to teach AI to be fair to all. Easy Text AI includes people with intellectual disabilities and autism as peer researchers.

  • Elangen, Inc.

    Elangen, Inc. - Safer ways to cure disease

  • Enamel Pure

    Healthy Enamel, Pure Smiles. Whether it is by way of cavities caused by bacteria or erosion caused by acidic beverages, dental enamel is at risk of acid mediated demineralization. Furthermore unlike other tissue, dental enamel once gone never grows back. Our mission at Enamel Pure is to help dental patients purify and preserve more of their dental enamel while experiencing fewer cavities and less dental erosion.

  • Fornax Biotech

    Next-generation sequencing, bioinformatics, and RNA-related services. Fornax Biotech offers RNA related services such as RNA purification and enrichment, mRNA and CRISPR guide RNA synthesis. We have rich experiences in Genomic DNA-, Amplicon-, RNA-, small RNA-, ChIP-Seq library preparation. We provide both standard bioinformatics analysis to understand your NGS data and customized software development to support novel techniques. We also offer a broad range of molecular biology services as well as kit development.

  • Hessian Labs

    Hessian Labs harnesses information from platelets, a highly responsive biological system, to build non-invasive tools with ‘next level’ diagnostic capability.

  • Highspin Biosystems

  • Leal Therapeutics

    Leal Therapeutics is a CNS-focused biotech start-up working to develop a pipeline of novel, ultra-precise therapeutics for major CNS indications.

  • MassVentures

    MassVentures is a venture studio at its core with an emphasis on academic spinouts and building diverse teams that convert research and early-stage ideas into companies serving underserved areas in the Commonwealth. By providing not only financial resources but also strategic direction, operational support, and access to a network of experts, MassVentures provides portfolio companies a greater chance of success.

  • Metro Biotech

    Metro Biotech is a privately-owned clinical-stage pharmaceutical company that has established the most comprehensive portfolio of proprietary NAD+ precursors in the world.

  • Microgradient Fluidics

    Microgradient Fluidics is developing custom instrumentation for quantifying protein stability, protein-protein interactions, protein size and protein folding kinetics. We also perform contract work for low-volume, label-free and surface-free measurements of protein stability using our automated confocal UV microscope with TCSPC detection. Microfluidics for quantifying biomolecule stability and interactions.

  • Neurotech Pharmaceuticals, Inc.

    Neurotech's innovative technology will improve the quality of life for people with chronic retinal disease. Neurotech has spent years developing the science, technology, team and manufacturing behind NT-501. As a result of a unique partnership and clear direction, we are focused on bringing a long-term treatment to Macular Telangiectasia (MacTel) patients.

  • Non Human Primate Reagent Resource (NHPRR)

    NHPRR supports innovation, reproducibility, and translation of preclinical research with high-quality biologics development

  • Phio Pharmaceuticals

    Phio's focus is centered on the application of self-delivering RNAi therapies in the field of immuno-oncology. Our INTASYL technology is the only self-delivering siRNA technology focused on immuno-oncology. INTASYL is designed to silence specific genes that are implicated in the proliferation of solid cancer tumors.

  • Prana Biosciences

    Prana Biosciences' mission is to develop, and manufacture cost-effective "biobetter" versions of the world's most successful monoclonal antibodies (mAbs) for a broader patient population. We are a biotech merging robust, established best-practice antibody development practices with advanced AI-supported enhancements in binding, function, and patient safety.

  • Prothia

    Prothia is a device manufacturing company specializing in cardiovascular, perinatal, and rehabilitation applications.

  • Quantum Technology Group

    Quantum's unique manufacturing process presents the ability to produce nontoxic quantum dots and deliver bulk manufacturing

  • SignaBlok, Inc.

    SignaBlok, Inc. is a biopharmaceutical company on a fast track to success. Founded in 2009 to develop novel targeted therapeutics and delivery nanosystems through the use of our revolutionary science and technologies, we offer high quality innovation, science and management expertise, encouraging results, an impressive IP portfolio, and growing involvement in international research.

  • SpadXTech

    SpadXTech seeks to significantly reduce CO2 emissions through the manufacturing of various carbon negative cellulose-based materials. Through its material platform technology and versatility, they can potentially impact the packaging, textiles, transportation, filtration, and the construction industries.

  • Spatial Surgical

    Novel first in class orthopedic laser system that rapidly and safely ablates soft tissue and bone through a single handpiece

  • Splice Histology

    Splice provide timely, high-quality, individual histopathology services when you need them.

  • Targeted Cell Therapies

    Novel oral delivery treatment for Gaucher disease.

  • Trilogie Bioscience

  • VirRNA

  • Volta Energy

    Volta Energy is developing next generation electrochemical energy storage technologies for renewable electricity including flow batteries and electrolyzers.

  • X Therapeutics

    Startup developing a new generation of medicines against infectious diseases

  • ZATA Pharmaceuticals

    Transforming blood transfusion through pathogen inactivation.